750 related articles for article (PubMed ID: 9506682)
1. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II infusion ameliorates the early phase of a mesangioproliferative glomerulonephritis.
Wenzel UO; Thaiss F; Helmchen U; Stahl RA; Wolf G
Kidney Int; 2002 Mar; 61(3):1020-9. PubMed ID: 11849457
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta receptors in self-limited vs. chronic progressive nephritis in rats.
Watanabe T; Yamamoto T; Ikegaya N; Fujigaki Y; Suzuki H; Togawa A; Fukasawa H; Nagase M; Hishida A
J Pathol; 2002 Nov; 198(3):397-406. PubMed ID: 12375273
[TBL] [Abstract][Full Text] [Related]
4. Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels.
Agarwal R; Siva S; Dunn SR; Sharma K
Am J Kidney Dis; 2002 Mar; 39(3):486-92. PubMed ID: 11877567
[TBL] [Abstract][Full Text] [Related]
5. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
Zoja C; Corna D; Bruzzi I; Foglieni C; Bertani T; Remuzzi G; Benigni A
Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
[TBL] [Abstract][Full Text] [Related]
6. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
Nakamura T; Obata J; Kimura H; Ohno S; Yoshida Y; Kawachi H; Shimizu F
Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924
[TBL] [Abstract][Full Text] [Related]
7. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R
J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
[TBL] [Abstract][Full Text] [Related]
8. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
Ciechanowicz A
Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
[TBL] [Abstract][Full Text] [Related]
9. Intrarenal RAS activity and urinary angiotensinogen excretion in anti-thymocyte serum nephritis rats.
Ohashi N; Yamamoto T; Huang Y; Misaki T; Fukasawa H; Suzuki H; Togawa A; Suzuki S; Fujigaki Y; Nakagawa T; Nakamura Y; Suzuki F; Kitagawa M; Hishida A
Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1512-8. PubMed ID: 18784264
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis.
Narita I; Border WA; Ketteler M; Noble NA
Lab Invest; 1995 Jan; 72(1):17-24. PubMed ID: 7837786
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.
Mizobuchi M; Morrissey J; Finch JL; Martin DR; Liapis H; Akizawa T; Slatopolsky E
J Am Soc Nephrol; 2007 Jun; 18(6):1796-806. PubMed ID: 17513326
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats.
Remuzzi A; Malanchini B; Battaglia C; Bertani T; Remuzzi G
Exp Nephrol; 1996; 4(1):19-25. PubMed ID: 8788596
[TBL] [Abstract][Full Text] [Related]
13. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
[TBL] [Abstract][Full Text] [Related]
14. Renal effects of long-term leptin infusion and preventive role of losartan treatment in rats.
Gunduz Z; Dursun N; Akgun H; Ozturk F; Okur H; Koc N
Regul Pept; 2005 Dec; 132(1-3):59-66. PubMed ID: 16229907
[TBL] [Abstract][Full Text] [Related]
15. The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
Zoja C; Donadelli R; Corna D; Testa D; Facchinetti D; Maffi R; Luzzana E; Colosio V; Bertani T; Remuzzi G
Am J Kidney Dis; 1997 Feb; 29(2):254-64. PubMed ID: 9016898
[TBL] [Abstract][Full Text] [Related]
16. Dietary salt intake modulates progression of antithymocyte serum nephritis through alteration of glomerular angiotensin II receptor expression.
Suzuki H; Yamamoto T; Ikegaya N; Hishida A
Am J Physiol Renal Physiol; 2004 Feb; 286(2):F267-77. PubMed ID: 14559715
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo transfer of the decorin gene into rat glomerulus via a mesangial cell vector suppressed extracellular matrix accumulation in experimental glomerulonephritis.
Huijun W; Long C; Zhigang Z; Feng J; Muyi G
Exp Mol Pathol; 2005 Feb; 78(1):17-24. PubMed ID: 15596056
[TBL] [Abstract][Full Text] [Related]
18. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
Volpini RA; da Silva CG; Costa RS; Coimbra TM
Diabetes Metab Res Rev; 2003; 19(1):43-51. PubMed ID: 12592643
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II increases intrarenal transforming growth factor-beta1 in rats submitted to sodium overload independently of blood pressure.
Rosón MI; Cao G; Della Penna S; Gorzalczany S; Pandolfo M; Toblli JE; Fernández BE
Hypertens Res; 2008 Apr; 31(4):707-15. PubMed ID: 18633183
[TBL] [Abstract][Full Text] [Related]
20. S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis.
Martini S; Krämer S; Loof T; Wang-Rosenke Y; Daig U; Budde K; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1761-70. PubMed ID: 17356129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
